A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS

Clinical trial NCT00656448 · COMPLETED

Trial details

NCT number: NCT00656448
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Myelodysplastic Syndrome Leukemia

Start date: 2008-03-01
Primary completion: 2013-06-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.